Sanofi (SNY) Profit After Tax (QoQ) (2009 - 2026)

Sanofi (SNY) Profit After Tax (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Mar 31, 2026	124.57%
Dec 31, 2025	-176.37%
Sep 30, 2025	126.38%
Jun 30, 2025	124.21%
Mar 31, 2025	316.87%
Dec 31, 2024	-84.71%
Sep 30, 2024	159.65%
Jun 30, 2024	-3.38%
Mar 31, 2024	229.14%
Dec 31, 2023	-134.89%
Sep 30, 2023	75.34%
Jun 30, 2023	-26.93%
Mar 31, 2023	-33.28%
Dec 31, 2022	54.19%
Sep 30, 2022	61.02%
Jun 30, 2022	-42.49%
Mar 31, 2022	73.43%
Dec 31, 2021	-52.62%
Sep 30, 2021	89.68%
Jun 30, 2021	-23.70%